Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Salim Nidal
A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Unmet Needs in the Treatment of Metastatic Non-Small-Cell Lung Cancer
European Oncology and Haematology
Oncology
Hematology
Profile of Ramucirumab in the Treatment of Metastatic Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma
Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Network Meta-Analysis
Immunotherapy
Oncology
Allergy
Immunology
Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Gefitinib for the Treatment of Non-Small-Cell Lung Cancer
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
PLoS ONE
Multidisciplinary
Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer
BMJ